Summary report for "anacreintexas.blogspot.com" (monthly stats)

Quick navigation: Traffic summary Adwords keywords & texts Organic keywords Competitors

Advertising budget: N/A

This site in Alpha Directory: a an ana

Approximate SE paid and organic traffic

	Traffic	Est. Cost
Organic keywords	2.06	$1.05*
Paid keywords	N/A	N/A

* — "Est. Cost" for organic traffic means amount of money the site owner would pay for such traffic if he bought it in PPC systems.

Try our new SERPTrends addon

SERPTrends add-on allows one to monitor SERP changes and view SEM parameters for sites while using Google, Yahoo! or BING search engines on the fly. Add-on adds trends and a drop-down box with SEM parameters near each search result.

Learn more about SERP Trends addon »

Organic keywords

	Keyword	Cost Equiv.	Position			Keyword	Traffic	Position			Keyword		Position
1.	blue heron bio	$1.05	9		1.	blue heron bio	2	9		1.	blue heron bio		9

Competitors for "anacreintexas.blogspot.com"

Genengnews.com: Genetic Engineering & Biotechnology News - Biotech from Bench to Business

Keywords: gen; genta; genetic engineering; lead optimization; biotechnology news;

Paid traffic cost: N/A

Businesswire.com: Press release distribution, EDGAR filing, XBRL, regulatory filings | Business Wire

Business Wire is the leading source for full-text breaking news and press releases, multimedia and regulatory filings for companies and groups throughout the world.

Keywords: telefonica net; amazon.fr; ditech; business wire; chase card services;

Paid traffic cost: $69.84

Hotfrog.com: Hot Frog - Your USA Business Directory

Keywords: california psychics; laptop battery; hot frog; blooming tea; handrails;

Paid traffic cost: N/A

Ir.lifetechnologies.com: Investor Relations | Life Technologies

Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables, reagents and services enable researchers to accelerate scientific exploration.

Keywords: informax; geneart; life investor; pcr instrument; tals;

Paid traffic cost: N/A